Alira Health Advises Guala Closures on Acquisition of KWK

Alira Health Advises Guala Closures on Acquisition of KWK

December 8, 2025

We are pleased to have served as commercial due diligence (CDD) advisors to Guala Closures, a global leader in specialty closure solutions, supporting its acquisition of KWK, an Austrian manufacturer of plastic caps and closures and precision dosing devices.

We are honored to have partnered with Guala Closures through our CDD support as they expand into the pharmaceutical packaging market, KWK's deep specialization in pharmaceutical packaging, combined with Guala's global leadership across multiple markets, represents a strong strategic fit and creates exciting opportunities for future growth."

Michal RaciborskiManaging Partner, Financial Sponsors, Alira Health

Founded in 1950 and headquartered in Kremsmünster, Austria, KWK Kunststoffwerk Kremsmünster serves a broad portfolio of global clients, including leading multinational pharmaceutical companies. The company has a strong presence in high-growth pharmaceutical and nutraceutical markets.

"We are honored to have partnered with Guala Closures through our CDD support as they expand into the pharmaceutical packaging market," said Dr. Michal Raciborski, Managing Partner Financial Sponsors, at Alira Health. "KWK's deep specialization in pharmaceutical packaging, combined with Guala's global leadership across multiple markets, represents a strong strategic fit and creates exciting opportunities for future growth."

This engagement underscores Alira Health's role as a trusted CDD advisor. Our work supports confident, growth-oriented decisions that help advance innovation across the healthcare sector. For more details on the KWK acquisition by Guala Closures, read the full press release on Guala Closures website. To learn more about Alira Health's Commercial Due Diligence services, visit alirahealth.com .